Brief Report
Version 1
Preserved in Portico This version is not peer-reviewed
Can Innate Immunity Flatten the Curve? Covid-19 – A Case Study
Version 1
: Received: 19 April 2020 / Approved: 19 April 2020 / Online: 19 April 2020 (16:54:43 CEST)
How to cite: Banerjee, S. Can Innate Immunity Flatten the Curve? Covid-19 – A Case Study. Preprints 2020, 2020040353. https://doi.org/10.20944/preprints202004.0353.v1 Banerjee, S. Can Innate Immunity Flatten the Curve? Covid-19 – A Case Study. Preprints 2020, 2020040353. https://doi.org/10.20944/preprints202004.0353.v1
Abstract
We have proposed a model considering two equally sized population (group A and group B) with low and high levels of disease tolerance. We have argued that in the more tolerant group (group B) the progression of the disease with respect to time will be slow with lower number of infections at any given time. We attribute this effect to the innate immunity which advantageously, can also be one of the major contributing factors for flattening the curve. We have compared the growth of Covid-19 disease in various countries to understand this effect.
Keywords
COVID-19; innate immunity
Subject
Biology and Life Sciences, Immunology and Microbiology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment